论文部分内容阅读
目的分析肝癌介入治疗出现严重并发症的原因,探讨规避的对策。方法回顾近年530例肝癌介入治疗病例,筛选出现严重并发症的,予以分析总结。结果 530例中术后急性胆囊炎发作1例;急性胃溃疡1例;坏死性胆管脓肿1例;急性肺水肿致死1例;多器官功能衰竭1例;肠系膜动脉栓塞1例。合计共有严重并发症6例,比率为1.13%。结论介入治疗后严重并发症的比率相对较小,原因多样;仔细观察及时应对,可减少危害。
Objective To analyze the causes of severe complications in interventional therapy of hepatocellular carcinoma (HCC) and explore the countermeasures. Methods A retrospective analysis of 530 cases of liver cancer interventional treatment in recent years, screening for serious complications, be analyzed and summarized. Results One hundred and fifty-three cases of acute cholecystitis occurred after operation. There were 1 case of acute gastric ulcer, 1 case of necrotic bile duct abscess, 1 case of acute pulmonary edema, 1 case of multiple organ failure and 1 case of mesenteric artery embolization. Total a total of 6 cases of serious complications, the rate was 1.13%. Conclusions The rate of serious complications after interventional therapy is relatively small for a variety of reasons. Careful observation and timely response can reduce the harm.